Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1061984

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1061984

Global Non-Melanoma Skin Cancer Market Insights and Forecast to 2028

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.

Market Analysis and Insights: Global Non-Melanoma Skin Cancer Market

The global Non-Melanoma Skin Cancer market size is projected to reach US$ 691.2 million by 2028, from US$ 524.9 million in 2021, at a CAGR of 3.9% during 2022-2028.

Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikely to cede this commanding position anytime soon.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Melanoma Skin Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Melanoma Skin Cancer market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Melanoma Skin Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Melanoma Skin Cancer market.

Global Non-Melanoma Skin Cancer Scope and Market Size

Non-Melanoma Skin Cancer market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Non-Melanoma Skin Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Chemotherapy
  • Radiation Therapy
  • Photodynamic Therapy

Segment by Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Company

  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly
  • Roche
  • Merck
  • Novartis
  • Mylan
  • Sun Pharmaceutical
  • Almirall
  • Elekta
  • Varian Medical Systems
  • Sensus Healthcare
  • iCAD
  • Accuray
  • Ion Beam Applications

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Non-Melanoma Skin Cancer Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Chemotherapy
    • 1.2.3 Radiation Therapy
    • 1.2.4 Photodynamic Therapy
  • 1.3 Market by Application
    • 1.3.1 Global Non-Melanoma Skin Cancer Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Ambulatory Surgical Centers
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Non-Melanoma Skin Cancer Market Perspective (2017-2028)
  • 2.2 Non-Melanoma Skin Cancer Growth Trends by Region
    • 2.2.1 Non-Melanoma Skin Cancer Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Non-Melanoma Skin Cancer Historic Market Size by Region (2017-2022)
    • 2.2.3 Non-Melanoma Skin Cancer Forecasted Market Size by Region (2023-2028)
  • 2.3 Non-Melanoma Skin Cancer Market Dynamics
    • 2.3.1 Non-Melanoma Skin Cancer Industry Trends
    • 2.3.2 Non-Melanoma Skin Cancer Market Drivers
    • 2.3.3 Non-Melanoma Skin Cancer Market Challenges
    • 2.3.4 Non-Melanoma Skin Cancer Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Non-Melanoma Skin Cancer Players by Revenue
    • 3.1.1 Global Top Non-Melanoma Skin Cancer Players by Revenue (2017-2022)
    • 3.1.2 Global Non-Melanoma Skin Cancer Revenue Market Share by Players (2017-2022)
  • 3.2 Global Non-Melanoma Skin Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Non-Melanoma Skin Cancer Revenue
  • 3.4 Global Non-Melanoma Skin Cancer Market Concentration Ratio
    • 3.4.1 Global Non-Melanoma Skin Cancer Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Non-Melanoma Skin Cancer Revenue in 2021
  • 3.5 Non-Melanoma Skin Cancer Key Players Head office and Area Served
  • 3.6 Key Players Non-Melanoma Skin Cancer Product Solution and Service
  • 3.7 Date of Enter into Non-Melanoma Skin Cancer Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Melanoma Skin Cancer Breakdown Data by Type

  • 4.1 Global Non-Melanoma Skin Cancer Historic Market Size by Type (2017-2022)
  • 4.2 Global Non-Melanoma Skin Cancer Forecasted Market Size by Type (2023-2028)

5 Non-Melanoma Skin Cancer Breakdown Data by Application

  • 5.1 Global Non-Melanoma Skin Cancer Historic Market Size by Application (2017-2022)
  • 5.2 Global Non-Melanoma Skin Cancer Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Non-Melanoma Skin Cancer Market Size (2017-2028)
  • 6.2 North America Non-Melanoma Skin Cancer Market Size by Type
    • 6.2.1 North America Non-Melanoma Skin Cancer Market Size by Type (2017-2022)
    • 6.2.2 North America Non-Melanoma Skin Cancer Market Size by Type (2023-2028)
    • 6.2.3 North America Non-Melanoma Skin Cancer Market Share by Type (2017-2028)
  • 6.3 North America Non-Melanoma Skin Cancer Market Size by Application
    • 6.3.1 North America Non-Melanoma Skin Cancer Market Size by Application (2017-2022)
    • 6.3.2 North America Non-Melanoma Skin Cancer Market Size by Application (2023-2028)
    • 6.3.3 North America Non-Melanoma Skin Cancer Market Share by Application (2017-2028)
  • 6.4 North America Non-Melanoma Skin Cancer Market Size by Country
    • 6.4.1 North America Non-Melanoma Skin Cancer Market Size by Country (2017-2022)
    • 6.4.2 North America Non-Melanoma Skin Cancer Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Non-Melanoma Skin Cancer Market Size (2017-2028)
  • 7.2 Europe Non-Melanoma Skin Cancer Market Size by Type
    • 7.2.1 Europe Non-Melanoma Skin Cancer Market Size by Type (2017-2022)
    • 7.2.2 Europe Non-Melanoma Skin Cancer Market Size by Type (2023-2028)
    • 7.2.3 Europe Non-Melanoma Skin Cancer Market Share by Type (2017-2028)
  • 7.3 Europe Non-Melanoma Skin Cancer Market Size by Application
    • 7.3.1 Europe Non-Melanoma Skin Cancer Market Size by Application (2017-2022)
    • 7.3.2 Europe Non-Melanoma Skin Cancer Market Size by Application (2023-2028)
    • 7.3.3 Europe Non-Melanoma Skin Cancer Market Share by Application (2017-2028)
  • 7.4 Europe Non-Melanoma Skin Cancer Market Size by Country
    • 7.4.1 Europe Non-Melanoma Skin Cancer Market Size by Country (2017-2022)
    • 7.4.2 Europe Non-Melanoma Skin Cancer Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Non-Melanoma Skin Cancer Market Size (2017-2028)
  • 8.2 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type
    • 8.2.1 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Non-Melanoma Skin Cancer Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application
    • 8.3.1 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Non-Melanoma Skin Cancer Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Region
    • 8.4.1 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Non-Melanoma Skin Cancer Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Non-Melanoma Skin Cancer Market Size (2017-2028)
  • 9.2 Latin America Non-Melanoma Skin Cancer Market Size by Type
    • 9.2.1 Latin America Non-Melanoma Skin Cancer Market Size by Type (2017-2022)
    • 9.2.2 Latin America Non-Melanoma Skin Cancer Market Size by Type (2023-2028)
    • 9.2.3 Latin America Non-Melanoma Skin Cancer Market Share by Type (2017-2028)
  • 9.3 Latin America Non-Melanoma Skin Cancer Market Size by Application
    • 9.3.1 Latin America Non-Melanoma Skin Cancer Market Size by Application (2017-2022)
    • 9.3.2 Latin America Non-Melanoma Skin Cancer Market Size by Application (2023-2028)
    • 9.3.3 Latin America Non-Melanoma Skin Cancer Market Share by Application (2017-2028)
  • 9.4 Latin America Non-Melanoma Skin Cancer Market Size by Country
    • 9.4.1 Latin America Non-Melanoma Skin Cancer Market Size by Country (2017-2022)
    • 9.4.2 Latin America Non-Melanoma Skin Cancer Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Non-Melanoma Skin Cancer Market Size (2017-2028)
  • 10.2 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type
    • 10.2.1 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Non-Melanoma Skin Cancer Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application
    • 10.3.1 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Non-Melanoma Skin Cancer Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Country
    • 10.4.1 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Non-Melanoma Skin Cancer Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Boehringer Ingelheim
    • 11.1.1 Boehringer Ingelheim Company Details
    • 11.1.2 Boehringer Ingelheim Business Overview
    • 11.1.3 Boehringer Ingelheim Non-Melanoma Skin Cancer Introduction
    • 11.1.4 Boehringer Ingelheim Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.1.5 Boehringer Ingelheim Recent Developments
  • 11.2 Bristol-Myers Squibb
    • 11.2.1 Bristol-Myers Squibb Company Details
    • 11.2.2 Bristol-Myers Squibb Business Overview
    • 11.2.3 Bristol-Myers Squibb Non-Melanoma Skin Cancer Introduction
    • 11.2.4 Bristol-Myers Squibb Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.2.5 Bristol-Myers Squibb Recent Developments
  • 11.3 Eli Lilly
    • 11.3.1 Eli Lilly Company Details
    • 11.3.2 Eli Lilly Business Overview
    • 11.3.3 Eli Lilly Non-Melanoma Skin Cancer Introduction
    • 11.3.4 Eli Lilly Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.3.5 Eli Lilly Recent Developments
  • 11.4 Roche
    • 11.4.1 Roche Company Details
    • 11.4.2 Roche Business Overview
    • 11.4.3 Roche Non-Melanoma Skin Cancer Introduction
    • 11.4.4 Roche Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.4.5 Roche Recent Developments
  • 11.5 Merck
    • 11.5.1 Merck Company Details
    • 11.5.2 Merck Business Overview
    • 11.5.3 Merck Non-Melanoma Skin Cancer Introduction
    • 11.5.4 Merck Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.5.5 Merck Recent Developments
  • 11.6 Novartis
    • 11.6.1 Novartis Company Details
    • 11.6.2 Novartis Business Overview
    • 11.6.3 Novartis Non-Melanoma Skin Cancer Introduction
    • 11.6.4 Novartis Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.6.5 Novartis Recent Developments
  • 11.7 Mylan
    • 11.7.1 Mylan Company Details
    • 11.7.2 Mylan Business Overview
    • 11.7.3 Mylan Non-Melanoma Skin Cancer Introduction
    • 11.7.4 Mylan Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.7.5 Mylan Recent Developments
  • 11.8 Sun Pharmaceutical
    • 11.8.1 Sun Pharmaceutical Company Details
    • 11.8.2 Sun Pharmaceutical Business Overview
    • 11.8.3 Sun Pharmaceutical Non-Melanoma Skin Cancer Introduction
    • 11.8.4 Sun Pharmaceutical Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.8.5 Sun Pharmaceutical Recent Developments
  • 11.9 Almirall
    • 11.9.1 Almirall Company Details
    • 11.9.2 Almirall Business Overview
    • 11.9.3 Almirall Non-Melanoma Skin Cancer Introduction
    • 11.9.4 Almirall Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.9.5 Almirall Recent Developments
  • 11.10 Elekta
    • 11.10.1 Elekta Company Details
    • 11.10.2 Elekta Business Overview
    • 11.10.3 Elekta Non-Melanoma Skin Cancer Introduction
    • 11.10.4 Elekta Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.10.5 Elekta Recent Developments
  • 11.11 Varian Medical Systems
    • 11.11.1 Varian Medical Systems Company Details
    • 11.11.2 Varian Medical Systems Business Overview
    • 11.11.3 Varian Medical Systems Non-Melanoma Skin Cancer Introduction
    • 11.11.4 Varian Medical Systems Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.11.5 Varian Medical Systems Recent Developments
  • 11.12 Sensus Healthcare
    • 11.12.1 Sensus Healthcare Company Details
    • 11.12.2 Sensus Healthcare Business Overview
    • 11.12.3 Sensus Healthcare Non-Melanoma Skin Cancer Introduction
    • 11.12.4 Sensus Healthcare Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.12.5 Sensus Healthcare Recent Developments
  • 11.13 iCAD
    • 11.13.1 iCAD Company Details
    • 11.13.2 iCAD Business Overview
    • 11.13.3 iCAD Non-Melanoma Skin Cancer Introduction
    • 11.13.4 iCAD Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.13.5 iCAD Recent Developments
  • 11.14 Accuray
    • 11.14.1 Accuray Company Details
    • 11.14.2 Accuray Business Overview
    • 11.14.3 Accuray Non-Melanoma Skin Cancer Introduction
    • 11.14.4 Accuray Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.14.5 Accuray Recent Developments
  • 11.15 Ion Beam Applications
    • 11.15.1 Ion Beam Applications Company Details
    • 11.15.2 Ion Beam Applications Business Overview
    • 11.15.3 Ion Beam Applications Non-Melanoma Skin Cancer Introduction
    • 11.15.4 Ion Beam Applications Revenue in Non-Melanoma Skin Cancer Business (2017-2022)
    • 11.15.5 Ion Beam Applications Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Non-Melanoma Skin Cancer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Chemotherapy
  • Table 3. Key Players of Radiation Therapy
  • Table 4. Key Players of Photodynamic Therapy
  • Table 5. Global Non-Melanoma Skin Cancer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 6. Global Non-Melanoma Skin Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Non-Melanoma Skin Cancer Market Size by Region (2017-2022) & (US$ Million)
  • Table 8. Global Non-Melanoma Skin Cancer Market Share by Region (2017-2022)
  • Table 9. Global Non-Melanoma Skin Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 10. Global Non-Melanoma Skin Cancer Market Share by Region (2023-2028)
  • Table 11. Non-Melanoma Skin Cancer Market Trends
  • Table 12. Non-Melanoma Skin Cancer Market Drivers
  • Table 13. Non-Melanoma Skin Cancer Market Challenges
  • Table 14. Non-Melanoma Skin Cancer Market Restraints
  • Table 15. Global Non-Melanoma Skin Cancer Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global Non-Melanoma Skin Cancer Revenue Share by Players (2017-2022)
  • Table 17. Global Top Non-Melanoma Skin Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Melanoma Skin Cancer as of 2021)
  • Table 18. Ranking of Global Top Non-Melanoma Skin Cancer Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by Non-Melanoma Skin Cancer Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players Non-Melanoma Skin Cancer Product Solution and Service
  • Table 22. Date of Enter into Non-Melanoma Skin Cancer Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Non-Melanoma Skin Cancer Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global Non-Melanoma Skin Cancer Revenue Market Share by Type (2017-2022)
  • Table 26. Global Non-Melanoma Skin Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global Non-Melanoma Skin Cancer Revenue Market Share by Type (2023-2028)
  • Table 28. Global Non-Melanoma Skin Cancer Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global Non-Melanoma Skin Cancer Revenue Share by Application (2017-2022)
  • Table 30. Global Non-Melanoma Skin Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global Non-Melanoma Skin Cancer Revenue Share by Application (2023-2028)
  • Table 32. North America Non-Melanoma Skin Cancer Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America Non-Melanoma Skin Cancer Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America Non-Melanoma Skin Cancer Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America Non-Melanoma Skin Cancer Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America Non-Melanoma Skin Cancer Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America Non-Melanoma Skin Cancer Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe Non-Melanoma Skin Cancer Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe Non-Melanoma Skin Cancer Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe Non-Melanoma Skin Cancer Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe Non-Melanoma Skin Cancer Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe Non-Melanoma Skin Cancer Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe Non-Melanoma Skin Cancer Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia Pacific Non-Melanoma Skin Cancer Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia Pacific Non-Melanoma Skin Cancer Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Non-Melanoma Skin Cancer Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Non-Melanoma Skin Cancer Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Non-Melanoma Skin Cancer Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Non-Melanoma Skin Cancer Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. Latin America Non-Melanoma Skin Cancer Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. Latin America Non-Melanoma Skin Cancer Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. Latin America Non-Melanoma Skin Cancer Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. Latin America Non-Melanoma Skin Cancer Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. Latin America Non-Melanoma Skin Cancer Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. Latin America Non-Melanoma Skin Cancer Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East and Africa Non-Melanoma Skin Cancer Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East and Africa Non-Melanoma Skin Cancer Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Non-Melanoma Skin Cancer Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Non-Melanoma Skin Cancer Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Non-Melanoma Skin Cancer Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Non-Melanoma Skin Cancer Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. Boehringer Ingelheim Company Details
  • Table 63. Boehringer Ingelheim Business Overview
  • Table 64. Boehringer Ingelheim Non-Melanoma Skin Cancer Product
  • Table 65. Boehringer Ingelheim Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 66. Boehringer Ingelheim Recent Developments
  • Table 67. Bristol-Myers Squibb Company Details
  • Table 68. Bristol-Myers Squibb Business Overview
  • Table 69. Bristol-Myers Squibb Non-Melanoma Skin Cancer Product
  • Table 70. Bristol-Myers Squibb Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 71. Bristol-Myers Squibb Recent Developments
  • Table 72. Eli Lilly Company Details
  • Table 73. Eli Lilly Business Overview
  • Table 74. Eli Lilly Non-Melanoma Skin Cancer Product
  • Table 75. Eli Lilly Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 76. Eli Lilly Recent Developments
  • Table 77. Roche Company Details
  • Table 78. Roche Business Overview
  • Table 79. Roche Non-Melanoma Skin Cancer Product
  • Table 80. Roche Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 81. Roche Recent Developments
  • Table 82. Merck Company Details
  • Table 83. Merck Business Overview
  • Table 84. Merck Non-Melanoma Skin Cancer Product
  • Table 85. Merck Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 86. Merck Recent Developments
  • Table 87. Novartis Company Details
  • Table 88. Novartis Business Overview
  • Table 89. Novartis Non-Melanoma Skin Cancer Product
  • Table 90. Novartis Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 91. Novartis Recent Developments
  • Table 92. Mylan Company Details
  • Table 93. Mylan Business Overview
  • Table 94. Mylan Non-Melanoma Skin Cancer Product
  • Table 95. Mylan Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 96. Mylan Recent Developments
  • Table 97. Sun Pharmaceutical Company Details
  • Table 98. Sun Pharmaceutical Business Overview
  • Table 99. Sun Pharmaceutical Non-Melanoma Skin Cancer Product
  • Table 100. Sun Pharmaceutical Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 101. Sun Pharmaceutical Recent Developments
  • Table 102. Almirall Company Details
  • Table 103. Almirall Business Overview
  • Table 104. Almirall Non-Melanoma Skin Cancer Product
  • Table 105. Almirall Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 106. Almirall Recent Developments
  • Table 107. Elekta Company Details
  • Table 108. Elekta Business Overview
  • Table 109. Elekta Non-Melanoma Skin Cancer Product
  • Table 110. Elekta Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 111. Elekta Recent Developments
  • Table 112. Varian Medical Systems Company Details
  • Table 113. Varian Medical Systems Business Overview
  • Table 114. Varian Medical Systems Non-Melanoma Skin Cancer Product
  • Table 115. Varian Medical Systems Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 116. Varian Medical Systems Recent Developments
  • Table 117. Sensus Healthcare Company Details
  • Table 118. Sensus Healthcare Business Overview
  • Table 119. Sensus Healthcare Non-Melanoma Skin Cancer Product
  • Table 120. Sensus Healthcare Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 121. Sensus Healthcare Recent Developments
  • Table 122. iCAD Company Details
  • Table 123. iCAD Business Overview
  • Table 124. iCAD Non-Melanoma Skin Cancer Product
  • Table 125. iCAD Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 126. iCAD Recent Developments
  • Table 127. Accuray Company Details
  • Table 128. Accuray Business Overview
  • Table 129. Accuray Non-Melanoma Skin Cancer Product
  • Table 130. Accuray Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 131. Accuray Recent Developments
  • Table 132. Ion Beam Applications Company Details
  • Table 133. Ion Beam Applications Business Overview
  • Table 134. Ion Beam Applications Non-Melanoma Skin Cancer Product
  • Table 135. Ion Beam Applications Revenue in Non-Melanoma Skin Cancer Business (2017-2022) & (US$ Million)
  • Table 136. Ion Beam Applications Recent Developments
  • Table 137. Research Programs/Design for This Report
  • Table 138. Key Data Information from Secondary Sources
  • Table 139. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Non-Melanoma Skin Cancer Market Share by Type: 2021 VS 2028
  • Figure 2. Chemotherapy Features
  • Figure 3. Radiation Therapy Features
  • Figure 4. Photodynamic Therapy Features
  • Figure 5. Global Non-Melanoma Skin Cancer Market Share by Application: 2021 VS 2028
  • Figure 6. Hospitals Case Studies
  • Figure 7. Clinics Case Studies
  • Figure 8. Ambulatory Surgical Centers Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. Non-Melanoma Skin Cancer Report Years Considered
  • Figure 11. Global Non-Melanoma Skin Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Non-Melanoma Skin Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Non-Melanoma Skin Cancer Market Share by Region: 2021 VS 2028
  • Figure 14. Global Non-Melanoma Skin Cancer Market Share by Players in 2021
  • Figure 15. Global Top Non-Melanoma Skin Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Melanoma Skin Cancer as of 2021)
  • Figure 16. The Top 10 and 5 Players Market Share by Non-Melanoma Skin Cancer Revenue in 2021
  • Figure 17. North America Non-Melanoma Skin Cancer Market Size YoY (2017-2028) & (US$ Million)
  • Figure 18. North America Non-Melanoma Skin Cancer Market Size Market Share by Type (2017-2028)
  • Figure 19. North America Non-Melanoma Skin Cancer Market Size Market Share by Application (2017-2028)
  • Figure 20. North America Non-Melanoma Skin Cancer Market Size Share by Country (2017-2028)
  • Figure 21. United States Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe Non-Melanoma Skin Cancer Market Size YoY (2017-2028) & (US$ Million)
  • Figure 24. Europe Non-Melanoma Skin Cancer Market Size Market Share by Type (2017-2028)
  • Figure 25. Europe Non-Melanoma Skin Cancer Market Size Market Share by Application (2017-2028)
  • Figure 26. Europe Non-Melanoma Skin Cancer Market Size Share by Country (2017-2028)
  • Figure 27. Germany Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Russia Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Nordic Countries Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Asia-Pacific Non-Melanoma Skin Cancer Market Size YoY (2017-2028) & (US$ Million)
  • Figure 34. Asia Pacific Non-Melanoma Skin Cancer Market Size Market Share by Type (2017-2028)
  • Figure 35. Asia Pacific Non-Melanoma Skin Cancer Market Size Market Share by Application (2017-2028)
  • Figure 36. Asia Pacific Non-Melanoma Skin Cancer Market Size Share by Region (2017-2028)
  • Figure 37. China Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Japan Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South Korea Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Southeast Asia Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. India Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Australia Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Latin America Non-Melanoma Skin Cancer Market Size YoY (2017-2028) & (US$ Million)
  • Figure 44. Latin America Non-Melanoma Skin Cancer Market Size Market Share by Type (2017-2028)
  • Figure 45. Latin America Non-Melanoma Skin Cancer Market Size Market Share by Application (2017-2028)
  • Figure 46. Latin America Non-Melanoma Skin Cancer Market Size Share by Country (2017-2028)
  • Figure 47. Mexico Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Brazil Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Non-Melanoma Skin Cancer Market Size YoY (2017-2028) & (US$ Million)
  • Figure 50. Middle East and Africa Non-Melanoma Skin Cancer Market Size Market Share by Type (2017-2028)
  • Figure 51. Middle East and Africa Non-Melanoma Skin Cancer Market Size Market Share by Application (2017-2028)
  • Figure 52. Middle East and Africa Non-Melanoma Skin Cancer Market Size Share by Country (2017-2028)
  • Figure 53. Turkey Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Saudi Arabia Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. UAE Non-Melanoma Skin Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Boehringer Ingelheim Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 58. Eli Lilly Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 59. Roche Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 60. Merck Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 61. Novartis Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 62. Mylan Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 63. Sun Pharmaceutical Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 64. Almirall Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 65. Elekta Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 66. Varian Medical Systems Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 67. Sensus Healthcare Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 68. iCAD Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 69. Accuray Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 70. Ion Beam Applications Revenue Growth Rate in Non-Melanoma Skin Cancer Business (2017-2022)
  • Figure 71. Bottom-up and Top-down Approaches for This Report
  • Figure 72. Data Triangulation
  • Figure 73. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!